Jeff Craven - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jeff Craven's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jeff Craven

Jeff Craven

Verified

Medical Writer, Freelance

Final Covers

travel, health social justice., cultureScience, feminism

Journalist Type

-

Seniority Positions

Medium Formats

Content

Total articles 420

  • ¿Fármacos para reducir la glucosa y un menor riesgo de demencia?

    By Jeff Craven| Medscape Noticias Médicas Verified Los agonistas del receptor del péptido similar al glucagón de tipo 1 (GLP-1RA) y los inhibidores del cotransportador de sodio-glucosa de tipo 2 (SGLT2i) están asociados con un riesgo significativamente menor de demencia y demencia relacionada con la enfermedad de Alzheimer, según mostraron los hallazgos de dos nuevos estudios.

    By Jeff Craven · Medscape Noticias Médicas

    Apr. 16, 2025

  • Novel Blood Test Could Help Diagnose, Track Alzheimer’s

    By Jeff Craven| Medscape Verified A novel blood test that detects a key biomarker for Alzheimer’s disease (AD) could help physicians more accurately determine the presence and track disease progression. The test measures levels of the protein MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — a biomarker of tau tangles in the brain that may be a more accurate measure of tau pathology than other established biomarkers.

    By Jeff Craven · Medscape

    Apr. 09, 2025

  • ¿Fármacos para reducir la glucosa y un menor riesgo de demencia?

    By Jeff Craven| Medscape Noticias Médicas Verified Los agonistas del receptor del péptido similar al glucagón de tipo 1 (GLP-1RA) y los inhibidores del cotransportador de sodio-glucosa de tipo 2 (SGLT2i) están asociados con un riesgo significativamente menor de demencia y demencia relacionada con la enfermedad de Alzheimer, según mostraron los hallazgos de dos nuevos estudios.

    By Jeff Craven · Medscape Noticias Médicas

    Apr. 16, 2025

As seen in

Company Info

Freelance

Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.

De Pere, Wisconsin, United States